Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2013, Article ID 642836, 5 pages
Clinical Study

Robotic Intracorporeal Ileal Conduit Formation: Initial Experience from a Single UK Centre

Hertfordshire and South Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage SG14AB, UK

Received 10 June 2013; Revised 27 July 2013; Accepted 31 July 2013

Academic Editor: Nazareno Suardi

Copyright © 2013 Conrad V. Bishop et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Objectives. To describe our technique of robotic intracorporeal ileal conduit formation (RICIC) during robotic-assisted radical cystectomy (RARC). To report our initial results of this new procedure. Patients and Methods. Seven male and one female patients underwent RARC with RICIC over a six-month period. Demographic, operative, and outcome data was collected prospectively. Median patient age was 75 years (range 62–78 years). Median followup was 9 months (range 7–14 months). Results. RARC with RICIC was performed successfully in all eight patients. The median total operating time was 360 minutes (range 310–440 minutes) with a median blood loss of 225 mL (range 50–1000 mL). The median length of stay was nine days (range 6–34 days). Four patients (50%) were discharged within seven days. Four patients (50%) experienced one or more complications. This included two Clavien I complications, two Clavien II complications, and two Clavien III complications. Two patients (25%) required transfusion of two units each. To date, there have been no complications associated with the ileal conduit. Conclusion. Whilst being technically challenging, this procedure is safe, feasible, and reproducible. Patients who avoid complication show potential for rapid recovery and early discharge.